Article info
PDFClinical science
Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma
- Correspondence to M Ashwin Reddy, Department of Ophthalmology, Barts Health NHS Trust, London, E1 1BB, UK; mashwinreddy{at}hotmail.com
Citation
Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma
Publication history
- Received February 5, 2017
- Revised March 20, 2017
- Accepted March 22, 2017
- First published April 21, 2017.
Online issue publication
November 23, 2017
Article Versions
- Previous version (23 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.